Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 8Psoriasis 7Lymphoma, Follicular 4Leukemia 4Myelodysplastic Syndromes 3Asthma 3Vasculitis 2Respiratory Distress Syndrome 2Recurrence 2Pneumonia 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Inflammation 2Granulomatosis with Polyangiitis 2Bronchiolitis Obliterans 2Arthritis, Psoriatic 2Arthritis, Juvenile 2Wilms Tumor 1Uveitis 1Temporomandibular Joint Disorders 1Spondylitis, Ankylosing 1Spondylarthritis 1Pruritus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plaque, Amyloid 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms 1Metabolic Syndrome 1

Interventions

guselkumab 2Etanercept 2tofacitinib 1Vaccines 1Saline Solution 1Infliximab 1Herpes Zoster Vaccine 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Arthritis, Psoriatic × Etanercept × Clear all
NCT01060098 2020-01-18

T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade

Imperial College London

Completed
48 enrolled 6 charts

Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Psoriatic

NCT00432406 2009-03-11

Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis

Chinese University of Hong Kong

Phase 4 Completed
40 enrolled

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡